Cargando…

2599. Impact of Alveolar Neutrophilia on Outcomes in Patients with Suspected Ventilated Hospital-Acquired Bacterial Pneumonia

BACKGROUND: Ventilated hospital-acquired bacterial pneumonia (vHABP) is a major source of morbidity & mortality in hospitalized patients. Clinical risk scores and systemic biomarkers have limited clinical & prognostic utility in vHABP. Alveolar biomarkers—specifically alveolar neutrophilia (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saravolatz, Louis, Albin, Owen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678082/ http://dx.doi.org/10.1093/ofid/ofad500.2214

Ejemplares similares

177. Follow-up Respiratory Cultures in Suspected Ventilator-associated Pneumonia: An Opportunity for Diagnostic Stewardship
por: Gomez, Cyndi Gonzalez, et al.
Publicado: (2022)

Teaching an Old Intensivist Neutrophil Tricks: Using Alveolar Neutrophilia to Diagnose Ventilator-associated Pneumonia
por: Gautam, Samir, et al.
Publicado: (2019)

2599. Studying the Effects of Altering Histone Modification on Aspergillus fumigatus Virulence
por: Lee, Pam, et al.
Publicado: (2019)

Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia
por: Albin, Owen R, et al.
Publicado: (2022)

791. ICU Provider Overestimation of Ventilator-Associated Pneumonia Diagnostic Probability: An Opportunity for Diagnostic Stewardship
por: Soper, Nathaniel, et al.
Publicado: (2022)

2170. Association Between End-of-Treatment Procalcitonin Levels with Mortality & Recurrent Ventilator-Associated Pneumonia
por: Schuiteman, Sam, et al.
Publicado: (2022)

2586. Comparison of Antimicrobial Regimens for Critically Ill Patients with Suspected or Confirmed Hospital-Acquired or Ventilator-Associated Pneumonia: A Retrospective, Cohort Study
por: Kosharek, Abigail, et al.
Publicado: (2023)

Descriptive Epidemiology and Outcomes of Nonventilated Hospital-Acquired, Ventilated Hospital-Acquired, and Ventilator-Associated Bacterial Pneumonia in the United States, 2012–2019
por: Zilberberg, Marya D., et al.
Publicado: (2021)

1476. Objective Surveillance Definitions for Hospital-Acquired Pneumonia in Non-Ventilated Patients
por: Ji, Wenjing, et al.
Publicado: (2018)

2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia
por: Albin, Owen, et al.
Publicado: (2019)

1464. The Clinical Features of Pneumonia Caused by Legionella pneumophila vs. Streptococcus pneumoniae: A Retrospective Study
por: Salahie, Sima, et al.
Publicado: (2018)

2724. Community-acquired Pneumonia in Immunocompromised Patients: Predictors and Outcomes Associated with Empiric Broad-spectrum Antibiotic Treatment
por: Saravolatz, Louis, et al.
Publicado: (2023)

93. Enhanced Oral Care as Prevention for Non-ventilator Hospital Acquired Pneumonia
por: Giuliano, Karen K, et al.
Publicado: (2020)

1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia
por: Mazi, Patrick B, et al.
Publicado: (2020)

2002. Evaluation of the BioFire(®) Pneumonia Panel in ICU Patients With Suspected Ventilator-Associated Pneumonia
por: Iannello, Alexandra, et al.
Publicado: (2018)

Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
por: Naik, Jaesh, et al.
Publicado: (2021)

1472. Antibiotic De-escalation Compared with Continued Empirical Treatment in Non-Ventilated Hospital-Acquired Pneumonia
por: Alnaimi, Shaikha, et al.
Publicado: (2018)

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
por: Motowski, Hayley, et al.
Publicado: (2023)

Experience with the management of 2599 cases of congenital muscular torticollis and a multicenter epidemiological investigation in 17 hospitals in China
por: Zhao, Zhenhui, et al.
Publicado: (2023)

PB2599: THE FREQUENCY OF PHENOTYPES OF THE MNS, KIDD, DUFFY SYSTEMS IN PATIENTS OF THE HEMATOLOGY CLINIC
por: Yovdiy, Anna, et al.
Publicado: (2023)

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial
por: Stergiopoulos, Stella, et al.
Publicado: (2018)

Cost–effectiveness of imipenem/cilastatin/relebactam for hospital-acquired and ventilator-associated bacterial pneumonia
por: Naik, Jaesh, et al.
Publicado: (2023)

Bacterial burden and bronchoalveolar cytokines in mechanically ventilated patients with suspected pneumonia
por: García, Á Estella, et al.
Publicado: (2007)

Evaluation of a Multiplex PCR Assay with Molecular Beacon Probes to Rapidly Detect Bacterial Pathogens Directly in Bronchial Alveolar Lavage (BAL) Samples from Patients with Hospital-Acquired Pneumonia (HAP)
por: Chavda, Kalyan D, et al.
Publicado: (2017)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

1940. Real-Life Impact of Pneumococcal Conjugate Vaccines (PCVs) on Hospitalization of Young Children with RSV-Associated Community-acquired Alveolar Pneumonia (CAAP)
por: Dagan, Ron, et al.
Publicado: (2023)

Valuation of bacteriological quantitative cultures obtained by broncho-alveolar lavages in ventilator-associated pneumonia
por: Gruson, D, et al.
Publicado: (1997)

2794. Testing and Treatment in Patients Hospitalized with Suspected Influenza Pneumonia
por: Deshpande, Abhishek, et al.
Publicado: (2019)

624. Probability of Target Attainment of Ceftolozane/Tazobactam Among Adult Patients with Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Secondary to Pseudomonas aeruginosa in Latin America
por: Okuma, Aline, et al.
Publicado: (2022)

90. The Diagnosis of Ventilator-associated pneumonia (DIVA) trial: Results of a Clinical Trial of a Bundled VAP Diagnostic Stewardship Intervention
por: Albin, Owen, et al.
Publicado: (2023)

Incidence and outcomes of hospitalization for community-acquired, ventilator-associated and non-ventilator hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain
por: Lopez-de-Andres, Ana, et al.
Publicado: (2020)

382. Incidence of Hospital-Acquired and Ventilator-Associated Pneumonia in Patients with Severe COVID 19 on High Flow Oxygen
por: Papamanoli, Aikaterini, et al.
Publicado: (2020)

Viruses are prevalent in non-ventilated hospital-acquired pneumonia
por: Shorr, Andrew F., et al.
Publicado: (2017)

The role of monocytosis and neutrophilia in atherosclerosis
por: Chistiakov, Dimitry A., et al.
Publicado: (2018)

1230. Clinical and Microbiologic Outcomes by Causative Pathogen in Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (HABP/VABP) Treated with Imipenem/Cilastatin (IMI)/Relebactam (REL) Versus Piperacillin/Tazobactam (PIP/TAZ)
por: Losada, Maria C, et al.
Publicado: (2020)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
por: Jung, Yun Jung, et al.
Publicado: (2022)

Correction: Incidence and outcomes of hospitalization for community-acquired, Ventilator-associated and non-ventilator Hospital-acquired pneumonias in patients with type 2 diabetes mellitus in Spain
Publicado: (2020)

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2018)

2618. Four Respiratory Viruses are Involved in the Majority of Community-Acquired Alveolar Pneumonia (CAAP) Episodes in Children < 5 Years
por: Dagan, Ron, et al.
Publicado: (2023)

1462. Hospital Admission Patterns in Adult Patients with Community-Acquired Bacterial Pneumonia Who Received Ceftriaxone and a Macrolide by Pneumonia Severity Index Score
por: Lodise, Thomas, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_spk5n9ilve9ai7v210abhm2i45